Range Cancer Therapeutics ETF - USD Stock

ETF

CNCR

US26922A8264

Market Closed - Nasdaq 04:15:00 2024-05-17 pm EDT 5-day change 1st Jan Change
15.2 USD -0.46% Intraday chart for Range Cancer Therapeutics ETF - USD +2.29% +12.84%
Current month+2.98%
1 month+4.32%
Dynamic Chart

Investment objective

The Loncar Cancer Immunotherapy ETF trades on Nasdaq under the symbol CNCR. It is made of up a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space that may have a foundational impact on cancer care. By developing immunotherapies that are more effective and deliver a better quality of life than currently available medicines, innovative immunotherapy companies may be making a difference for courageous patients who battle cancer. Our fund seeks to support this important work and its positive impact on society. It tracks the LCINDX index.
Name
Price
Change
5d. change
1st Jan change
Weight
7.65 USD -1.29%-5.79%+52.39%2.84%
39.41 USD +1.08%+5.80%+37.41%2.32%
4.39 USD +7.86%+10.03%-31.83%2.27%
4.365 USD -14.75%+31.87%-54.63%2.09%
105 USD -1.58%-1.63%+13.79%1.77%
3.9 USD -5.80%-4.41%+4.28%1.76%
53.62 USD +1.57%+7.80%-3.39%1.69%
32.68 USD +1.78%+3.94%-20.60%1.69%
See all (82)
In partnership with
TrackInsight
Date Price Change Volume
24-05-17 15.2 -0.46% 18,715
24-05-16 15.27 +0.20% 6,613
24-05-15 15.24 +2.08% 2,507
24-05-14 14.93 -0.60% 2,797
24-05-13 15.02 +1.08% 2,534

Delayed Quote Nasdaq

Last update May 17, 2024 at 04:15 pm EDT

More quotes

Description

US26922A8264
Total Expense Ratio 0.79%
Asset Class
Sector
Size
Currency
Provider
Underlying Range Oncology Therapeutics Index - USD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2015-03-16
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-04-29 )

AuM (EUR) 16 M€
AuM 1M 22 M€
AuM 3 months 14 M€
AuM 6 months 10 M€
AuM 12 months 15 M€
  1. Stock Market
  2. ETF
  3. CNCR ETF
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW